Glucagon III

Glucagon III complements Glucagon I and II published in 1983 in this series as Vols. 66/I and II. These three volumes truly represent a "glucagon encyclopedia" and as such have no competitors in the scientific literature worldwide. In this volume, the most recent data on glucagon molecular...

Full description

Bibliographic Details
Other Authors: Lefebvre, Pierre J. (Editor)
Format: eBook
Language:English
Published: Berlin, Heidelberg Springer Berlin Heidelberg 1996, 1996
Edition:1st ed. 1996
Series:Handbook of Experimental Pharmacology
Subjects:
Online Access:
Collection: Springer Book Archives -2004 - Collection details see MPG.ReNa
Table of Contents:
  • H. Human Glucagon Receptor
  • I. Conclusions
  • References
  • 5 Mode of Action of Glucagon Revisited
  • A. Introduction
  • B. Glucagon Actions Mediated Through Glucagon Receptors
  • C. Glucagon is Processed by Its Target Cells
  • D. Action of Mini-glucagon [Glucagon (19–29)] in Liver
  • E. Mini-glucagon Action in Heart
  • F. Glucagon and Mini-glucagon Act in Concert
  • G. Conclusion and Perspectives
  • References
  • 6 Pulsatility of Glucagon
  • A. Introduction
  • B. Oscillations in Glucagon Plasma Levels
  • C. Pulsatile Glucagon Secretion In Vitro
  • D. Pulsatile Glucagon Delivery In Vitro
  • E. Pulsatile Glucagon Delivery In Vivo
  • F. Conclusions
  • References
  • 7 Glucagon and Diabetes
  • A. Introduction
  • B. Diabetogenic Effects of Glucagon
  • C. The A Cell in Diabetes
  • D. Circulating Glucagon Levels in Diabetes
  • E. Glucagon Dysfunction in Diabetes
  • F.Role of Glucagon Excess in the Metabolic Abnormalities of Diabetes
  • G. Therapeutic Implications
  • H. Conclusions
  • 1 The Industrial Production of Glucagon
  • A. Introduction
  • B. Production
  • C. Analysis of Recombinant Human Glucagon
  • D. Stability
  • References
  • 2 The Glucagon Gene and Its Expression
  • A. Introduction
  • B. Structure
  • C. Expression
  • D. Conclusions
  • References
  • 3 Preproglucagon and Its Processing
  • A. Introduction
  • B. Tissue-Specific Post-translational Processing of Proglucagon
  • C. Role of Prohormone Convertases in Proglucagon Processing
  • D. Secondary, Postsecretory Processing of Proglucagon-Derived Peptides
  • E. Conclusions
  • References
  • 4 The Glucagon Receptor Gene: Organization and Tissue Distribution
  • A. Introduction
  • B. Cloning of the Glucagon Receptor
  • C. Organization of the Glucagon Receptor Gene
  • D. Tissue Distribution of the Glucagon Receptors
  • E. Tissue Distribution of Glucagon Receptor Transcripts
  • F. Regulation of Glucagon Receptor Gene Expression
  • G. Structure/Function Analysis of the Glucagon Receptor
  • References
  • 8 The Search for Glucagon Antagonists
  • A. Glucagon as a Drug Target
  • B. Search for a Glucagon Antagonist
  • References
  • 9 Glucagon and Glucose Counterregulation
  • A. Introduction
  • B. Glycemic Action of Glucagon
  • C. Glucagon Secretion
  • D. Role of Glucagon in Glucose Counterregulation
  • E. Conclusions
  • References
  • 10 Modes of Glucagon Administration
  • A. Introduction
  • B. Classic Routes of Administration
  • C. New Routes of Glucagon Administration
  • D. Conclusions
  • References
  • 11 The Place of Glucagon in Emergency Medicine
  • A. Hypoglycemia
  • B. Cardiovascular Insufficiency
  • C. Vascular Effects
  • D. Renal/Urologic Effects
  • E. Shock
  • F. Respiratory Effects
  • G. Gastrointestinal Effects
  • H. Radiographic Studies
  • I. Adverse Effects
  • References
  • 12 The Place of Glucagon in Medical Imaging
  • A. Introduction
  • B. Upper Gastrointestinal Tract
  • C. Small Bowel
  • D. Large Bowel
  • E. Biliary Tract
  • F. Other Applications
  • G. Side Effects and Contraindications
  • References
  • 13 The Glucagon Test for Evaluation of Insulin Secretion
  • A. Introduction
  • B. Methodological Aspects
  • C. Comparison with Other Stimuli
  • D. Clinical Applications
  • E. Conclusions
  • References
  • 14 Glucagon and the Control of Appetite
  • A. Introduction
  • B. Prandial Glucagon Secretion
  • C. Glucagon Administration and Food Intake
  • D. Glucagon Antagonism and Food Intake
  • E. Mechanism of Glucagon Satiety
  • F. Clinical Aspects
  • G. Conclusions
  • References
  • 15 Glucagonoma and Its Management
  • A. Introduction
  • B. Diagnosis and Localization of the Tumor
  • C. Management of the Glucagonoma Syndrome
  • D. Prognosis
  • E. Conclusions
  • References
  • 16 Structure and Functionof the Glucagon-Like Peptide-1 Receptor
  • A. Introduction
  • B. GLP-1 Receptor
  • C. Conclusions
  • References
  • 17 Physiology and Pathophysiology of GLP-1
  • A. The Incretin Concept
  • B. Origin, Processing, Secretion and Fate of GLP-1
  • C. Tissue Distribution of GLP-1 Receptors and Biological Actions
  • D. Signal Transduction of the GLP-1 Receptor
  • E. Pathophysiological Relevance?
  • References
  • 18 Potential of GLP-1 in Diabetes Management
  • A. Introduction
  • B. Actions of GLP-1 on Blood Glucose in Humans
  • C. Gastrointestinal Effects of GLP-1 in Humans
  • D. GLP-1 and Diabetes
  • E. GLP-1 Metabolism in Normal and Diabetic Subjects
  • F. Conclusion and Outlook
  • References
  • 19 Oxyntomodulin and Its Related Peptides
  • A. Introduction
  • B. Biological Characteristics of Oxyntomodulin
  • C. Conclusions
  • References